Published in Cancer Weekly, September 28th, 2004
"Using cDNA microarrays, overexpression of LAT-1 was found in 87.5% (7/8) of esophageal adenocarcinomas relative to 12 Barrett samples (33% metaplasia and 66% dysplasia) and was confirmed in 100% (28/28) of Barrett adenocarcinomas by quantitative reverse transcription polymerase chain reaction," in a study conducted by J. Lin and coauthors at the University of Michigan.
"Immunohistochemistry revealed LAT-1 staining in 37.5% (24/64)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.